Insights

Global Expansion AmbioPharm’s recent $28 million investment to expand its manufacturing facilities in Shanghai indicates a strong focus on increasing production capacity in Asia, presenting opportunities for supply chain collaborations and regional partnerships.

Leadership Growth The appointment of a new CEO and key executives like the Chief Commercial Officer demonstrates a strategic push towards market expansion and customer acquisition, making this an ideal time to offer value-added services or strategic alliances.

Strategic Partnerships AmbioPharm partners with biotech firms like CombiGene and Ariceum Therapeutics, signaling openness to collaborations for peptide development and contract manufacturing, which can drive new sales in peptide APIs and conjugates.

Financial Stability With revenues ranging from $50 million to $100 million and multiple FDA-inspected manufacturing sites, AmbioPharm shows strong market positioning and compliance, providing confidence in their capacity for large-scale and compliant manufacturing contracts.

Innovation & Technology Specializing in developing efficient processes for peptide APIs and operating state-of-the-art facilities, AmbioPharm is well-positioned to meet the high-quality demands of innovative biotech and pharmaceutical companies seeking reliable manufacturing partners.

Similar companies to AmbioPharm - A Global Peptide CDMO

AmbioPharm - A Global Peptide CDMO Tech Stack

AmbioPharm - A Global Peptide CDMO uses 8 technology products and services including Termly, React, imagesLoaded, and more. Explore AmbioPharm - A Global Peptide CDMO's tech stack below.

Termly
Cookie Compliance
React
Javascript Frameworks
imagesLoaded
Javascript Libraries
Moment.js
Javascript Libraries
Microsoft Project
Project Management
Bootstrap
UI Frameworks
X-Content-Type-Options
Web & Portal Technology
Apache
Web Servers

Media & News

AmbioPharm - A Global Peptide CDMO's Email Address Formats

AmbioPharm - A Global Peptide CDMO uses at least 1 format(s):

AmbioPharm - A Global Peptide CDMO Email Formats	Example	Percentage
First.Last@ambiopharm.com	John.Doe@ambiopharm.com	94%
Last@ambiopharm.com	Doe@ambiopharm.com	4%
FLast@ambiopharm.com	JDoe@ambiopharm.com	2%

Frequently Asked Questions

Where is AmbioPharm - A Global Peptide CDMO's headquarters located?

AmbioPharm - A Global Peptide CDMO's main headquarters is located at 1024 Dittman Court, North Augusta, SC 29842, US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is AmbioPharm - A Global Peptide CDMO's phone number?

You can contact AmbioPharm - A Global Peptide CDMO's main corporate office by phone at

+1-408-832-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AmbioPharm - A Global Peptide CDMO's official website and social media links?

AmbioPharm - A Global Peptide CDMO's official website is ambiopharm.com and has social profiles on LinkedIn Crunchbase.

How much revenue does AmbioPharm - A Global Peptide CDMO generate?

As of October 2025, AmbioPharm - A Global Peptide CDMO's annual revenue is estimated to be $4.6M.

What is AmbioPharm - A Global Peptide CDMO's SIC code NAICS code?

AmbioPharm - A Global Peptide CDMO's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AmbioPharm - A Global Peptide CDMO have currently?

As of October 2025, AmbioPharm - A Global Peptide CDMO has approximately 501 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer, Board Member: B. G.Chief Executive Officer: A. L.Chief Commercial Officer (cco): T. P. W.. Explore AmbioPharm - A Global Peptide CDMO's employee directory with LeadIQ.

What industry does AmbioPharm - A Global Peptide CDMO belong to?

AmbioPharm - A Global Peptide CDMO operates in the Pharmaceutical Manufacturing industry.

What technology does AmbioPharm - A Global Peptide CDMO use?

AmbioPharm - A Global Peptide CDMO's tech stack includes TermlyReactimagesLoadedMoment.jsMicrosoft ProjectBootstrapX-Content-Type-OptionsApache.

What is AmbioPharm - A Global Peptide CDMO's email format?

AmbioPharm - A Global Peptide CDMO's email format typically follows the pattern of First.Last@ambiopharm.com. Find more AmbioPharm - A Global Peptide CDMO email formats with LeadIQ.

When was AmbioPharm - A Global Peptide CDMO founded?

AmbioPharm - A Global Peptide CDMO was founded in 2005.

AmbioPharm - A Global Peptide CDMO

Q: What technology does AmbioPharm - A Global Peptide CDMO use?

AmbioPharm - A Global Peptide CDMO's tech stack includes imagesLoaded, X-Content-Type-Options, WooCommerce, Gutenberg Blocks, Apache.

Pharmaceutical ManufacturingUnited States501-1000 Employees

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.